Stocktoria

NP Life Sciences Health Industry Group Inc. ACAT

NP Life Sciences Health Industry Group Inc. statistics & valuation

Profitability & efficiency

Net margin (%)
-253.10% -873.80% -187.70% -18.50% -1.80% 20192020202120222023
Gross margin (%)
20192020202120222023
Operating margin (%)
-253.20% -873.90% -187.70% -18.50% -0.40% 20192020202120222023
Return on equity (%)
-46.30% -126.20% -172.10% -97.60% -17.90% 20192020202120222023
Shares outstanding
43.0M 43.0M 43.0M 43.0M 43.0M 20192020202120222023
Net debt ($)
20192020202120222023
Share buybacks ($)
20192020202120222023
Return on assets (%)
-43.50% -110.50% -171.00% -14.80% -3.80% 20192020202120222023
Free cash flow margin (%)
20192020202120222023
Debt / equity (×)
20192020202120222023
EPS ($)
$0.00 $0.00 20192020202120222023

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2023FY2022FY2021FY2020FY2019
Operating margin-0.4%-18.5%-187.7%-873.9%-253.2%
Net margin-1.8%-18.5%-187.7%-873.8%-253.1%
Return on assets-3.8%-14.8%-171.0%-110.5%-43.5%
Return on equity-17.9%-97.6%-172.1%-126.2%-46.3%

Computed from company filings · US · as of 2023-12-31. Facts plus Stocktoria's own computed scores — not investment advice.